SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia gains on raising Rs 50 crore through Commercial Papers

12 Aug 2025 Evaluate

Jubilant Ingrevia is currently trading at Rs. 702.10, up by 5.30 points or 0.76% from its previous closing of Rs. 696.80 on the BSE.

The scrip opened at Rs. 718.95 and has touched a high and low of Rs. 718.95 and Rs. 689.10 respectively. So far 11044 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 884.95 on 12-Dec-2024 and a 52 week low of Rs. 556.55 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 736.40 and Rs. 683.00 respectively. The current market cap of the company is Rs. 11180.74 crore.

The promoters holding in the company stood at 45.22%, while Institutions and Non-Institutions held 28.75% and 26.02% respectively.

Jubilant Ingrevia has raised Rs 50 crore through Commercial Papers (CPs) on August 11, 2025. Maturity date of the said Commercial Papers is September 25, 2025. Tenure of the instrument is 45 days.

The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 170 crore.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

735.50 36.20 (5.18%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3739.05
Tata Chemicals 707.80
SRF 2541.95
Pidilite Inds. 1402.25
Deepak Nitrite 1731.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×